ARCHIVES

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

This article is from The Cancer Letter archive.

Vol. 30 No. 27 | July 2, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

COMMIT Moving Into Implementation

July 15, 1988

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

February 25, 1977

First Lady Recalls 1992 Meeting With NBCC, Credits Group For Progress In Breast Cancer

May 8, 1998